Relationship between infrared skin radiation and functional tests in patients affected by Emery-Dreifuss muscular dystrophy: Part 2

relationships.isProjectOf

relationships.isOrgUnitOf

relationships.isJournalIssueOf

Abstract

Hypothesis: This study represents a second part of a recently published study about a new form of evaluation and development of rare genetic neurodegenerative diseases. The objective is to provide a more global vision of thermography with respect to the Emery-Dreifuss pathology, through the analysis of the data collection carried out for one year. The basic hypothesis is that thermography could become a valid tool for the diagnosis and follow-up of this pathology because is a very specific tool for registering temperature changes produced by a constant degenerative evolution of this muscular dystrophy.

Description

Hipótesis: Este estudio representa una segunda parte de un estudio recientemente publicado sobre una nueva forma de evaluación y desarrollo de enfermedades neurodegenerativas genéticas raras. El objetivo es proporcionar una visión más global de la termografía con respecto a la patología de Emery-Dreifuss, a través del análisis de la recogida de datos realizada durante un año. La hipótesis básica es que la termografía podría convertirse en una herramienta válida para el diagnóstico y seguimiento de esta patología por ser una herramienta muy específica para registrar los cambios de temperatura producidos por una constante evolución degenerativa de esta distrofia muscular.

Bibliographic citation

Cabizosu A, Berenguer-Vidal R, Vegara-Meseguer JM, Martínez-Almagro Andreo A, Maiquez Mojica V, Casu G, Carboni N. Relationship between infrared skin radiation and functional tests in patients affected by Emery-Dreifuss muscular dystrophy: Part 2. Med Hypotheses. 2021 Jan;146:110348. doi: 10.1016/j.mehy.2020.110348

Collections

Endorsement

Review

Supplemented By

Referenced By

Creative Commons license

Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 Internacional